Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery

Clinical trial NCT07032792 · RECRUITING

Trial details

NCT number: NCT07032792
Sponsor: Northwell Health
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cardiac Disease Surgery Bleeding

Start date: 2025-11-03
Primary completion: 2028-11-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.